Association of Indian Medical Device Industry, which represents domestic manufacturers, has welcomed the government proposal to extend price caps to devices including catheters and balloons which are used in angioplasties.
A government panel has recommended inclusion of these devices under price control following complaints of large scale overcharging by hospitals. The National Pharmaceutical Pricing Authority requested the government to classify balloons and catheters as drugs and include them under the National List of Essential Medicines.
The government had in February capped the price of stents by around 85 per cent. The move resulted in increased sales for domestic manufacturers which